HEADER HYDROLASE 17-APR-19 6JVO TITLE CRYSTAL STRUCTURE OF HUMAN MTH1 IN COMPLEX WITH COMPOUND MI1022 COMPND MOL_ID: 1; COMPND 2 MOLECULE: 7,8-DIHYDRO-8-OXOGUANINE TRIPHOSPHATASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: 2-HYDROXY-DATP DIPHOSPHATASE,8-OXO-DGTPASE,NUCLEOSIDE COMPND 5 DIPHOSPHATE-LINKED MOIETY X MOTIF 1,NUDIX MOTIF 1; COMPND 6 EC: 3.6.1.55,3.6.1.56; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NUDT1, MTH1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VARIANT: ROSETTA; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PET28A KEYWDS MTH1, OXIDATIVE DNA DAMAGE, 8-OXO-DGTP, INHIBITOR DEVELOPMENT, KEYWDS 2 HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR C.PENG,Y.H.LI,Y.S.CHENG REVDAT 4 22-NOV-23 6JVO 1 REMARK REVDAT 3 12-MAY-21 6JVO 1 JRNL REVDAT 2 18-NOV-20 6JVO 1 REMARK REVDAT 1 28-OCT-20 6JVO 0 JRNL AUTH C.PENG,Y.H.LI,C.W.YU,Z.H.CHENG,J.R.LIU,J.L.HSU,L.W.HSIN, JRNL AUTH 2 C.T.HUANG,H.F.JUAN,J.W.CHERN,Y.S.CHENG JRNL TITL INHIBITOR DEVELOPMENT OF MTH1 VIA HIGH-THROUGHPUT SCREENING JRNL TITL 2 WITH FRAGMENT BASED LIBRARY AND MTH1 SUBSTRATE BINDING JRNL TITL 3 CAVITY. JRNL REF BIOORG.CHEM. V. 110 04813 2021 JRNL REFN ISSN 0045-2068 JRNL PMID 33774493 JRNL DOI 10.1016/J.BIOORG.2021.104813 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.10.1_2155 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.80 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.7 REMARK 3 NUMBER OF REFLECTIONS : 25019 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.195 REMARK 3 R VALUE (WORKING SET) : 0.190 REMARK 3 FREE R VALUE : 0.248 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.840 REMARK 3 FREE R VALUE TEST SET COUNT : 1961 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 25.7950 - 4.5761 0.99 1802 154 0.2083 0.2625 REMARK 3 2 4.5761 - 3.6354 1.00 1721 145 0.1572 0.1971 REMARK 3 3 3.6354 - 3.1768 1.00 1708 146 0.1804 0.2355 REMARK 3 4 3.1768 - 2.8868 1.00 1689 144 0.2024 0.2672 REMARK 3 5 2.8868 - 2.6801 0.99 1647 140 0.2011 0.2362 REMARK 3 6 2.6801 - 2.5222 0.99 1672 141 0.1937 0.2758 REMARK 3 7 2.5222 - 2.3960 0.99 1653 141 0.1925 0.2508 REMARK 3 8 2.3960 - 2.2918 0.98 1646 140 0.1989 0.2842 REMARK 3 9 2.2918 - 2.2036 0.97 1615 139 0.1917 0.2412 REMARK 3 10 2.2036 - 2.1276 0.97 1611 138 0.1883 0.2508 REMARK 3 11 2.1276 - 2.0611 0.97 1641 136 0.1918 0.2583 REMARK 3 12 2.0611 - 2.0022 0.96 1575 136 0.2036 0.3063 REMARK 3 13 2.0022 - 1.9495 0.96 1605 134 0.2044 0.2760 REMARK 3 14 1.9495 - 1.9020 0.90 1473 127 0.2163 0.2810 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.200 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.440 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 22.15 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 30.07 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 2578 REMARK 3 ANGLE : 0.946 3484 REMARK 3 CHIRALITY : 0.061 360 REMARK 3 PLANARITY : 0.006 448 REMARK 3 DIHEDRAL : 15.988 1504 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): 15.6356 0.2346 -10.0230 REMARK 3 T TENSOR REMARK 3 T11: 0.1483 T22: 0.1543 REMARK 3 T33: 0.0957 T12: -0.0010 REMARK 3 T13: 0.0043 T23: 0.0175 REMARK 3 L TENSOR REMARK 3 L11: 1.8372 L22: 0.7637 REMARK 3 L33: 0.1245 L12: 0.5048 REMARK 3 L13: -0.0023 L23: -0.1679 REMARK 3 S TENSOR REMARK 3 S11: 0.0552 S12: -0.2218 S13: -0.1403 REMARK 3 S21: 0.0006 S22: -0.0312 S23: 0.0003 REMARK 3 S31: -0.0040 S32: -0.0465 S33: -0.0239 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : 1 REMARK 3 NCS GROUP : 1 REMARK 3 NCS OPERATOR : 1 REMARK 3 REFERENCE SELECTION: (CHAIN A AND (RESSEQ 3:13 OR RESSEQ 18:78 REMARK 3 OR RESSEQ 80:101 OR RESSEQ 103:156)) REMARK 3 SELECTION : (CHAIN B AND (RESSEQ 3:13 OR RESSEQ 18:78 REMARK 3 OR RESSEQ 80:101 OR RESSEQ 103:156)) REMARK 3 ATOM PAIRS NUMBER : 1380 REMARK 3 RMSD : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6JVO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 24-APR-19. REMARK 100 THE DEPOSITION ID IS D_1300011744. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 02-OCT-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 3.75 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSRRC REMARK 200 BEAMLINE : BL13B1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX300HE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25591 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 4.400 REMARK 200 R MERGE (I) : 0.06200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.97 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : 4.30 REMARK 200 R MERGE FOR SHELL (I) : 0.28900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 3ZR1 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.55 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.26 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% PEG 6000, 200 MM LITHIUM SULPHATE, REMARK 280 100 MM SODIUM ACETATE PH 3.75, EVAPORATION, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 29.48900 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 39.45050 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 34.09250 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 39.45050 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 29.48900 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 34.09250 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 2 REMARK 465 GLN B 14 REMARK 465 PRO B 15 REMARK 465 GLN B 16 REMARK 465 ARG B 17 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH B 373 O HOH B 404 2.04 REMARK 500 O HOH B 391 O HOH B 403 2.06 REMARK 500 O HOH B 376 O HOH B 394 2.08 REMARK 500 O HOH A 371 O HOH A 414 2.10 REMARK 500 O HOH A 407 O HOH A 418 2.14 REMARK 500 OE1 GLU B 77 O HOH B 301 2.17 REMARK 500 O HOH B 405 O HOH B 416 2.18 REMARK 500 O HOH B 355 O HOH B 381 2.18 REMARK 500 OD2 ASP B 154 O HOH B 302 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 427 DISTANCE = 6.40 ANGSTROMS REMARK 525 HOH A 428 DISTANCE = 6.57 ANGSTROMS REMARK 525 HOH B 417 DISTANCE = 6.33 ANGSTROMS REMARK 525 HOH B 418 DISTANCE = 6.61 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CJ6 A 200 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CJ6 B 200 DBREF 6JVO A 2 156 UNP P36639 8ODP_HUMAN 43 197 DBREF 6JVO B 2 156 UNP P36639 8ODP_HUMAN 43 197 SEQRES 1 A 155 GLY ALA SER ARG LEU TYR THR LEU VAL LEU VAL LEU GLN SEQRES 2 A 155 PRO GLN ARG VAL LEU LEU GLY MET LYS LYS ARG GLY PHE SEQRES 3 A 155 GLY ALA GLY ARG TRP ASN GLY PHE GLY GLY LYS VAL GLN SEQRES 4 A 155 GLU GLY GLU THR ILE GLU ASP GLY ALA ARG ARG GLU LEU SEQRES 5 A 155 GLN GLU GLU SER GLY LEU THR VAL ASP ALA LEU HIS LYS SEQRES 6 A 155 VAL GLY GLN ILE VAL PHE GLU PHE VAL GLY GLU PRO GLU SEQRES 7 A 155 LEU MET ASP VAL HIS VAL PHE CYS THR ASP SER ILE GLN SEQRES 8 A 155 GLY THR PRO VAL GLU SER ASP GLU MET ARG PRO CYS TRP SEQRES 9 A 155 PHE GLN LEU ASP GLN ILE PRO PHE LYS ASP MET TRP PRO SEQRES 10 A 155 ASP ASP SER TYR TRP PHE PRO LEU LEU LEU GLN LYS LYS SEQRES 11 A 155 LYS PHE HIS GLY TYR PHE LYS PHE GLN GLY GLN ASP THR SEQRES 12 A 155 ILE LEU ASP TYR THR LEU ARG GLU VAL ASP THR VAL SEQRES 1 B 155 GLY ALA SER ARG LEU TYR THR LEU VAL LEU VAL LEU GLN SEQRES 2 B 155 PRO GLN ARG VAL LEU LEU GLY MET LYS LYS ARG GLY PHE SEQRES 3 B 155 GLY ALA GLY ARG TRP ASN GLY PHE GLY GLY LYS VAL GLN SEQRES 4 B 155 GLU GLY GLU THR ILE GLU ASP GLY ALA ARG ARG GLU LEU SEQRES 5 B 155 GLN GLU GLU SER GLY LEU THR VAL ASP ALA LEU HIS LYS SEQRES 6 B 155 VAL GLY GLN ILE VAL PHE GLU PHE VAL GLY GLU PRO GLU SEQRES 7 B 155 LEU MET ASP VAL HIS VAL PHE CYS THR ASP SER ILE GLN SEQRES 8 B 155 GLY THR PRO VAL GLU SER ASP GLU MET ARG PRO CYS TRP SEQRES 9 B 155 PHE GLN LEU ASP GLN ILE PRO PHE LYS ASP MET TRP PRO SEQRES 10 B 155 ASP ASP SER TYR TRP PHE PRO LEU LEU LEU GLN LYS LYS SEQRES 11 B 155 LYS PHE HIS GLY TYR PHE LYS PHE GLN GLY GLN ASP THR SEQRES 12 B 155 ILE LEU ASP TYR THR LEU ARG GLU VAL ASP THR VAL HET CJ6 A 200 18 HET CJ6 B 200 18 HETNAM CJ6 N4-CYCLOPROPYL-6-(4-METHYLPIPERAZIN-1-YL)PYRIMIDINE-2, HETNAM 2 CJ6 4-DIAMINE FORMUL 3 CJ6 2(C12 H20 N6) FORMUL 5 HOH *246(H2 O) HELIX 1 AA1 THR A 44 GLY A 58 1 15 HELIX 2 AA2 PRO A 112 MET A 116 5 5 HELIX 3 AA3 ASP A 119 GLN A 129 1 11 HELIX 4 AA4 THR B 44 GLY B 58 1 15 HELIX 5 AA5 GLN B 107 ILE B 111 5 5 HELIX 6 AA6 PRO B 112 MET B 116 5 5 HELIX 7 AA7 TRP B 117 PRO B 118 5 2 HELIX 8 AA8 ASP B 119 GLN B 129 1 11 SHEET 1 AA1 4 TRP A 32 ASN A 33 0 SHEET 2 AA1 4 ARG A 17 LYS A 23 -1 N GLY A 21 O ASN A 33 SHEET 3 AA1 4 SER A 4 GLN A 14 -1 N GLN A 14 O ARG A 17 SHEET 4 AA1 4 MET A 101 GLN A 107 0 SHEET 1 AA213 PHE A 35 LYS A 38 0 SHEET 2 AA213 SER A 4 GLN A 14 -1 N VAL A 10 O PHE A 35 SHEET 3 AA213 ARG A 17 LYS A 23 -1 O ARG A 17 N GLN A 14 SHEET 4 AA213 LEU A 80 THR A 88 0 SHEET 5 AA213 HIS A 65 PHE A 74 -1 N ILE A 70 O VAL A 83 SHEET 6 AA213 PHE A 133 GLN A 140 1 O PHE A 139 N GLU A 73 SHEET 7 AA213 THR A 144 GLU A 152 -1 O LEU A 146 N LYS A 138 SHEET 8 AA213 THR B 144 GLU B 152 1 O GLU B 152 N LEU A 150 SHEET 9 AA213 PHE B 133 GLN B 140 -1 N LYS B 138 O LEU B 146 SHEET 10 AA213 HIS B 65 PHE B 74 1 N GLU B 73 O PHE B 139 SHEET 11 AA213 LEU B 80 THR B 88 -1 O VAL B 83 N ILE B 70 SHEET 12 AA213 SER B 4 VAL B 12 1 N ARG B 5 O ASP B 82 SHEET 13 AA213 PHE B 35 LYS B 38 -1 O PHE B 35 N VAL B 10 SHEET 1 AA3 2 THR A 60 VAL A 61 0 SHEET 2 AA3 2 ILE A 91 GLN A 92 -1 O GLN A 92 N THR A 60 SHEET 1 AA4 3 TRP B 32 ASN B 33 0 SHEET 2 AA4 3 LEU B 19 LYS B 23 -1 N GLY B 21 O ASN B 33 SHEET 3 AA4 3 MET B 101 TRP B 105 -1 O CYS B 104 N LEU B 20 SHEET 1 AA5 2 THR B 60 VAL B 61 0 SHEET 2 AA5 2 ILE B 91 GLN B 92 -1 O GLN B 92 N THR B 60 SITE 1 AC1 11 THR A 8 LEU A 9 ASN A 33 GLY A 37 SITE 2 AC1 11 PHE A 72 PHE A 74 TRP A 117 ASP A 119 SITE 3 AC1 11 ASP A 120 TRP A 123 PHE A 139 SITE 1 AC2 11 THR B 8 LEU B 9 ASN B 33 GLY B 37 SITE 2 AC2 11 PHE B 72 PHE B 74 TRP B 117 ASP B 119 SITE 3 AC2 11 ASP B 120 TRP B 123 PHE B 139 CRYST1 58.978 68.185 78.901 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016955 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014666 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012674 0.00000